{"id":16267,"date":"2026-11-04T18:11:07","date_gmt":"2026-11-04T15:11:07","guid":{"rendered":"https:\/\/www.ortaakarsu.net\/?page_id=16267"},"modified":"2026-11-04T18:11:07","modified_gmt":"2026-11-04T15:11:07","slug":"english-interaction-maraviroc-triflucan-100-mg","status":"publish","type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=16267","title":{"rendered":"Maraviroc and Fluconazole (Triflucan 100 mg): interaction and safety"},"content":{"rendered":"<h2>Interaction mechanism<\/h2>\n<p>Moderate CYP3A inhibition may increase maraviroc exposure.<\/p>\n<h2>Clinical significance and safety<\/h2>\n<p>EMA maraviroc information advises caution with fluconazole, the active ingredient in Triflucan 100 mg. Population pharmacokinetic data did not indicate that routine maraviroc adjustment was required; this differs from the strong-inhibitor rule. The clinician should review tolerability, renal function and all other medicines rather than applying that rule automatically.<\/p>\n<h2>Using this information<\/h2>\n<p>This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EMA maraviroc information advises caution with fluconazole, the active ingredient in Triflucan 100 mg. Population pharmacokinetic data did not indicate that routine maraviroc\u2026<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-16267","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages\/16267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16267"}],"version-history":[{"count":0,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/pages\/16267\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}